Company intelligence / Profile preview
Matinas BioPharma
Bedminster, New Jersey, United Statesmatinasbiopharma.com ↗
- Ownership
- Public · MTNB
- Employees
- ~15
- Development stage
- Other
01
Overview
MAT2203 demonstrated positive results in the completed Phase II EnACT study for cryptococcal meningitis in HIV patients—meeting its primary endpoint with robust survival data. However, following the termination of a key partnership negotiation in late October/early November 2024, all product development activities have been halted to conserve cash. The company implemented an immediate ~80% workforce reduction.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Small moleculesOligonucleotides (including mRNA, DNA plasmids, antisense oligonucleotides)Proteins and peptidesVaccines
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
BioNTech SE – evaluation of mRNA formats with LNC platformGenentech Inc. – oral formulations collaborationNational Institute of Allergy and Infectious Diseases – remdesivir oral formulation projectNational Resilience – technology/data collaboration
04
Financials
- Market cap
- $495.4K
- Total revenue
- $0
- Enterprise value
- $-259.6K
Beyond the preview
Go deeper on Matinas BioPharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Matinas BioPharma.